Comparative Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- M.D. Anderson Cancer Center
- Enrollment
- 110
- Locations
- 1
- Primary Endpoint
- Time to Any Complication Requiring Treatment
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The goal of this clinical research study is learn about side effects and the success of bronchoscopies when performed in cancer patients with and without symptoms.
This is an investigational study.
Up to 110 patients will take part in this study. All will be enrolled at MD Anderson.
Detailed Description
If participant agrees to take part in this study, researchers will collect information from participant's medical records. Length of Study: Researchers will continue to collect participant's medical information for up to 2 years. Additional Information: Participant's data will be kept in a database on a password-protected computer in a secure office. This information will only be available to the study doctors and staff.
Investigators
Eligibility Criteria
Inclusion Criteria
- •° All patients undergoing interventional bronchoscopy during the first 12 months will be enrolled, with follow-up occurring out to 2 years from the study startup (the duration of the grant).
Exclusion Criteria
- •Age less than 18 years,
- •Inability to participate in telephone follow-up
Outcomes
Primary Outcomes
Time to Any Complication Requiring Treatment
Time Frame: 2 years
Researchers will estimate the hazard function of time to any complications in the framework of competing risks while death is the competing risk.3 Researchers will graphically visualize the hazard function of time to any complications using Kernel smoothing method.
Secondary Outcomes
- Quality-Adjusted Survival(2 years)